Recruiting studies: Arterial Or Venous Thrombosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or I
Phase N/A · 2 location(s) · Cardioangiologisches Centrum Bethanien · NCT06650826 Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT06904183 VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321 Aspiration Thrombectomy Using the Symphony or Prodigy System
Phase N/A · 8 location(s) · Imperative Care, Inc. · NCT07350499 BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07062055

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.